Back

Polypharmacy as an independent predictor of heart failure hospitalization and mortality in HFrEF patients

11 May 2026 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Contemporary management and outcome predictions Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joao Fernandes Pedro

Santa Maria Hospital - CHULN, Lisbon (Portugal)

5 More presentations in this session

Presentation thumbnail
One-year outcomes in patients with heart failure and chronic kidney disease: differences according to the type of heart failure and kidney disease stages
Doctor M. Anguita Sanchez (Cordoba, ES)
Abstract Slides
Presentation thumbnail
SMILE-HF registry: contemporary management, frailty profile, and 12-month outcomes of acute heart failure in Korea
Associate Professor S. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and outcomes of heart failure with reduced versus preserved ejection fraction and relationship with body mass index in a nationwide multi-ethnic Asian cohort
Doctor S. Tan (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Uric acid variation as a predictor of short- and long-term mortality in acute decompensated heart failure
Doctor F. Bahouth (Nazareth, IL)
Abstract Slides Video
Presentation thumbnail
Heart failure improvement, remission and recovery: patients characteristics and prognostic implications
Doctor F. Musella (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Contemporary management and outcome predictions

The Event

Event poster

Heart Failure 2026

11 May 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure (polypharmacy phenogroups and heart failure subgroups outcomes)
thumbnail
Congress Presentation
Clinical outcomes for patients with severe HFrEF diagnosed and treated in a community setting with the 'four pillars' of pharmacotherapy
thumbnail
Congress Presentation
Frailty and polypharmacy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources